Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
03/09/2011 | EP2292625A1 Substituted spiro compounds and their use for producing pain-relief medicaments |
03/09/2011 | EP2292622A1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
03/09/2011 | EP2292619A1 Purine derivatives for use as adenonsin A-2A receptor agonists |
03/09/2011 | EP2292617A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors |
03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
03/09/2011 | EP2292613A1 Dihydroindolinone derivatives |
03/09/2011 | EP2292610A1 Macrolides with VEGF transcription suppression activity |
03/09/2011 | EP2292589A1 Novel multifunctional peptidase inhibitors, especially for medical use |
03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
03/09/2011 | EP2292242A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof |
03/09/2011 | EP2292241A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof |
03/09/2011 | EP2292211A2 Mucoadhesive pharmaceutical formulations |
03/09/2011 | EP2292091A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
03/09/2011 | EP2291390A1 New optically pure compounds for improved therapeutic efficiency |
03/09/2011 | EP2291369A1 Phenyl and benzodioxinyl substituted indazoles derivatives |
03/09/2011 | EP2291359A1 Phenyl or pyridinyl substituted indazoles derivatives |
03/09/2011 | EP2291350A2 Compositions and methods for preparing and using same |
03/09/2011 | EP2291345A1 Co-crystals of duloxetine and cox-inhibitors for the treatment of pain |
03/09/2011 | EP2077998B1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
03/09/2011 | EP1888122B1 A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of tnf alpha and a carrier protein |
03/09/2011 | EP1841735B1 Indoles useful in the treatment of inflammation |
03/09/2011 | EP1824475B1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
03/09/2011 | EP1692116B1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
03/09/2011 | EP1622892B1 Indazoles having analgesic activity |
03/09/2011 | EP1355910B1 Formulation of boronic acid compounds |
03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
03/09/2011 | CN1651395B Borneol fatly acid ester derivative and preparation containing said derivative |
03/09/2011 | CN101983722A Composition for preventing and treating joint soft tissue injury and complications thereof |
03/09/2011 | CN101983698A Traditional Chinese medicine composition for treating rheumatic heart disease and preparation method thereof |
03/09/2011 | CN101983666A Traditional Chinese medicine composition for treating rheumatism and preparation method thereof |
03/09/2011 | CN101983662A Traditional Chinese medicine composition for treating sore throat and preparation method thereof |
03/09/2011 | CN101983653A Drug for treating lumbocrural pain and preparation method thereof |
03/09/2011 | CN101983652A Traditional Chinese medicine for treating scapulohumeral periarthritis |
03/09/2011 | CN101983631A Composition for treating infection of pseudomonas aeruginosa in chicken and preparation method thereof |
03/09/2011 | CN101411831B Medicament for treating low fever |
03/09/2011 | CN101077103B Inflammation-diminishing and cough-controlling tea |
03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
03/08/2011 | US7902366 NK1 antagonists |
03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
03/08/2011 | US7902208 Treating allergic and inflammatory conditions |
03/08/2011 | US7902192 Inhibitors of P38 and methods of using the same |
03/08/2011 | US7902164 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
03/08/2011 | US7902149 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
03/08/2011 | US7901879 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
03/08/2011 | US7901709 Active agent, a gel-phase lipid bilayer membrane of a phospholipid and a surface active agent contained in the bilayer membrane; increasing the percentage of active agent released at the phase transition temperature of the lipid bilayer |
03/08/2011 | CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
03/08/2011 | CA2422531C Topical analgesic compositions containing aliphatic polyamines and methods of using same |
03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
03/08/2011 | CA2361251C Formulations comprising antisense nucleotides to connexins |
03/08/2011 | CA2343840C Use of a cytokine-producing lactococcus strain to treat colitis |
03/03/2011 | WO2011025541A1 Cannabinoid receptor modulators |
03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
03/03/2011 | WO2011024122A1 Pharmaceutical compositions for treating ibd |
03/03/2011 | WO2011023986A1 Kinase inhibitors |
03/03/2011 | WO2011023812A1 Microsomal prostaglandin e synthase-1 (mpges1) inhibitors |
03/03/2011 | WO2011023626A1 Pyrrolidine derivatives as nk3 receptor antagonists |
03/03/2011 | WO2011023392A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an antiepileptic |
03/03/2011 | WO2010146348A3 Crystalline form of pemirolast |
03/03/2011 | WO2010145197A8 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors |
03/03/2011 | WO2010124163A3 Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies |
03/03/2011 | WO2010111240A3 Methods for treating inflammatory arthritis |
03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
03/03/2011 | WO2008053362A3 Bioresponsive polymers |
03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
03/03/2011 | US20110054031 Ophthalmic NSAIDS as Adjuvants |
03/03/2011 | US20110054020 Napthylene inhibitors of cyclooxygenase |
03/03/2011 | US20110054011 RNA Antagonist Compounds for the Modulation of FABP4/AP2 |
03/03/2011 | US20110054003 Antisense oligonucleotide modulation of stat3 expression |
03/03/2011 | US20110053987 Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same |
03/03/2011 | US20110053986 Respiratory disease treatment |
03/03/2011 | US20110053985 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
03/03/2011 | US20110053984 Novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
03/03/2011 | US20110053982 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
03/03/2011 | US20110053980 Indane-amine derivatives, their preparation and use as medicaments |
03/03/2011 | US20110053976 Quinoline derivatives and their use as tyrosine kinase inhibitors |
03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
03/03/2011 | US20110053962 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
03/03/2011 | US20110053960 Method for treating pain syndrome and other disorders |
03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
03/03/2011 | US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
03/03/2011 | US20110053939 Novel aromatic nitro compounds |
03/03/2011 | US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
03/03/2011 | US20110053931 Quinoline compounds and methods of use |
03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
03/03/2011 | US20110053920 Substituted bicyclic pyrimidines |
03/03/2011 | US20110053917 Allosteric Modulators of the A1 Adenosine Receptor |
03/03/2011 | US20110053914 Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-Dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an Antiepileptic |
03/03/2011 | US20110053913 Methods and Therapies for Alleviating Pain |
03/03/2011 | US20110053912 Pyrimidine compound |